Diskussionsleitung: B. Al-Kassou (Bonn), F. Jansen (Bonn)
| (P1341) | Comparison of mortality risk models in patients with post-cardiac arrest cardiogenic shock and percutaneous mechanical circulatory support | |
| G. Chatzis, B. Markus, H. Ahrens, U. Lüsebrink, C. Wächter, D. Divchev, K. Karatolios, B. Schieffer, S. Syntila (Marburg, Gießen) | ||
| (P1342) | Vergleich der Herzunterstützungssysteme Impella und IABP bezüglich des Outcome bei Patienten mit kardiogenem Schock | |
| I. Tanev, G. Dernick, T. Rauwolf, A. Schmeißer, R. Braun-Dullaeus (Magdeburg) | ||
| (P1343) | Levosimendan has positive impact on the survival rate on VA-ECMO in eCPR and cardiogenic shock | |
| A. Dreher, A. Springer, J. Reimers, L. Kaiser, E. Bahlmann, H. Van der Schalk, P. Wohlmuth, N. Geßler, K. Hassan, S. Sheikhzadeh, J. Wietz, B. Bein, T. Spangenberg, S. Willems, S. Hakmi, E. P. Tigges (Hamburg) | ||
| (P1344) | De novo vs. acute-on-chronic heart failure-related cardiogenic shock | |
| J. Sundermeyer, F. Gustafsson, C. Kellner, B. Beer, L. C. Besch, A. Dettling, S. Blankenberg, P. Kirchhof, L. Bertoldi, J. Dauw, D. Eckner, I. Eitel, T. Graf, P. Horn, U. Landmesser, P. Lüdike, E. Lüsebrink, N. Mangner, O. Maniuc, S. Möbius-Winkler, P. Nordbeck, M. Orban, F. Pappalardo, M. Pauschinger, M. Pazdernik, A. Proudfoot, M. Kelham, T. Rassaf, C. Scherer, C. Schulze, R. H. G. Schwinger, C. Skurk, M. Sramko, G. Tavazzi, H. Thiele, L. Villanova, N. Morici, A. Wechsler, R. Westenfeld, D. Westermann, B. Schrage, für die Studiengruppe: NICSR Investigators (Hamburg, Nürnberg, Lübeck, Düsseldorf, Berlin, Essen, München, Dresden, Würzburg, Jena, Weiden i. d. Oberpfalz, Leipzig, Milan, Freiburg im Breisgau; Copenhagen, DK; Milano, Alessandria, Pavia, IT; Genk, BE; Prague, CZ; London, UK) | ||
| (P1345) | Clinical course of patients in cardiogenic shock stratified by phenotype | |
| E. Zweck, M. Kanwar, S. Sinha, K. Thayer, A. R. Garan, J. Hernandez-Montfort, Y. Zhang, B. Li, P. Baca, F. Dieng, N. M. Harwani, J. Abraham, G. Hickey, S. Nathan, D. Wencker, S. Hall, A. Schwartzmann, W. Khalife, S. Li, C. Mahr, J. H. Kim, E. Vorovich, E. H. Whitehead, V. Blumer, R. Westenfeld, D. Burkhoff, N. K. Kapur, für die Studiengruppe: CSWG (40225 Düsseldorf, Düsseldorf; Pittsburgh, Falls Chuch, Virginia, Boston, MA, Dallas, TX, Portland, OR, Pittsburgh, Pennsylvania, Chicago, IL, Portland, Maine, Galveston, TX, Seattle, Washington, Houston, TX, Durham, NC, New York, NY, US) | ||
| (P1346) | Peri-procedural Impella-CP® related complications and their impact on in-hospital mortality in patients with cardiogenic shock | |
| M. K. Alsaad, S. Schulze Lammers, A. Tego, N. B.. Danielsmeier, C. Köster, T. Lawrenz, C. Stellbrink (Bielefeld) | ||
| (P1347) | Renal protection with the use of percutaneous left ventricular assist device in female cardiogenic shock patients - Results from the Dresden Impella Registry | |
| J. Mierke, T. Nowack, T. Löhn, F. Pöge, M. C. Schuster, D. Baron, C. Pflücke, F. Woitek, S. Haussig, K. Ibrahim, N. Mangner, A. Linke (Dresden, Freiberg, Chemnitz) | ||
| (P1348) | The serum proteome of VA-ECMO patients changes over time and allows differentiation of survivors and non-survivors on day 3 | |
| P. M. Siegel, B. A. Barta, L. Orlean, T. Wengenmayer, G. Trummer, D. Wolf, D. Westermann, O. Schilling, P. Diehl (Freiburg, Freiburg im Breisgau, Lahr/Schwarzwald) |